Recently, large language models have been developed to enable conversations between scientists and artificial intelligence. It has even been used to generate potential drug targets. Several innovative biotech companies are tapping into the potential of these algorithms to facilitate the process of drug discovery. Microsoft and Google are currently exploring ChatGPT, a text generator engine, to improve search and prevent fraudulent activities, such as plagiarism and false news.
ChatGPT is a valuable asset for companies involved in drug discovery. With its advanced capabilities, it can help automate certain processes, streamline workflows, and increase the efficiency of drug development. Furthermore, AI-driven tools can be used to find patterns in vast amounts of data, improve the accuracy of predictions, and suggest drug candidates that have the potential of becoming the next big in the pharmaceutical industry.
One such company is OpenAI, a San Francisco-based AI research company. Founded in 2016, OpenAI has been leveraging large language models to produce human-like texts and has been successfully contributing to drug discovery with its AI-driven solutions. It’s most prominent innovation, ChatGPT provides a digital ‘drug discovery engine’ using textual context to generate potential drug candidates, offering insights to its customers.
Similarly, Japanese pharmaceuticals company Shinei Pharmaceuticals is leveraging digital trends and cutting-edge technologies to support its innovation in drug discovery, including AI-driven ChatGPT. They are currently developing a ‘Next-Generation Robot AI-Assisted Drug Discovery Service’, using AI to ‘think’ and generate ideas to aid their drug discovery process.
The pioneering work of these companies in drug discovery through the utilization of modern technology, such as ChatGPT, has the potential to benefit humankind immensely, and pave the way for a revolution in the healthcare industry. OpenAI and Shinei Pharmaceuticals are exemplary in exploring the potential of AI and ChatGPT technology to drive the drug discovery process and revolutionise the way new drugs are discovered and developed.
